AQR Capital Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Sell |
53,171
-20,404
| -28% | -$41.5K | ﹤0.01% | 3162 |
|
|
2025
Q1 | $120K | Buy |
+73,575
| New | +$120K | ﹤0.01% | 2980 |
|
|
2023
Q4 | – | Sell |
-37,476
| Closed | -$175K | – | 2386 |
|
|
2023
Q3 | $175K | Buy |
+37,476
| New | +$175K | ﹤0.01% | 2160 |
|
|
2021
Q2 | – | Sell |
-3,030
| Closed | -$337K | – | 2260 |
|
|
2021
Q1 | $337K | Sell |
3,030
-3,946
| -57% | -$439K | ﹤0.01% | 1970 |
|
|
2020
Q4 | $741K | Sell |
6,976
-2,624
| -27% | -$279K | ﹤0.01% | 1633 |
|
|
2020
Q3 | $1.34M | Buy |
9,600
+4,248
| +79% | +$591K | ﹤0.01% | 1274 |
|
|
2020
Q2 | $1.73M | Buy |
+5,352
| New | +$1.73M | ﹤0.01% | 1217 |
|
|
2017
Q3 | – | Sell |
-1,526
| Closed | -$144K | – | 2262 |
|
|
2017
Q2 | $144K | Sell |
1,526
-839
| -35% | -$79.2K | ﹤0.01% | 2158 |
|
|
2017
Q1 | $188K | Sell |
2,365
-883
| -27% | -$70.2K | ﹤0.01% | 2119 |
|
|
2016
Q4 | $271K | Sell |
3,248
-1,960
| -38% | -$164K | ﹤0.01% | 2082 |
|
|
2016
Q3 | $582K | Buy |
+5,208
| New | +$582K | ﹤0.01% | 1897 |
|
|
2015
Q3 | – | Sell |
-898
| Closed | -$88K | – | 2211 |
|
|
2015
Q2 | $88K | Hold |
898
| – | – | ﹤0.01% | 2174 |
|
|
2015
Q1 | $88K | Sell |
898
-3,985
| -82% | -$391K | ﹤0.01% | 2089 |
|
|
2014
Q4 | $538K | Sell |
4,883
-942
| -16% | -$104K | ﹤0.01% | 1930 |
|
|
2014
Q3 | $689K | Hold |
5,825
| – | – | ﹤0.01% | 1809 |
|
|
2014
Q2 | $756K | Hold |
5,825
| – | – | ﹤0.01% | 1781 |
|
|
2014
Q1 | $931K | Buy |
5,825
+2,940
| +102% | +$470K | ﹤0.01% | 1737 |
|
|
2013
Q4 | $402K | Buy |
+2,885
| New | +$402K | ﹤0.01% | 2168 |
|